{"product_id":"hioscar-swot-analysis","title":"Oscar Health SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Preview—Access the Full Strategic Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOscar Health's blend of tech-driven care coordination and consumer-focused plans positions it well in value-based markets, but margin pressure, regulatory complexity, and competitive incumbents pose real risks; operational execution and expansion into Medicare Advantage will be key near-term catalysts. Discover the full SWOT analysis for a research-backed, editable report and Excel tools to support investment, strategy, or deal-making decisions—available for purchase now.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Full-Stack Technology Platform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOscar Health’s home-grown Mario full-stack platform integrates claims, clinical records, and member engagement, cutting admin overhead; by Q4 2025 Oscar reported medical loss ratio-adjusted admin costs roughly 8–10% below major legacy peers, per company disclosures.\u003c\/p\u003e\n\u003cp\u003eMario’s modular architecture lets Oscar push new features in weeks not quarters, supporting a 22% year-over-year increase in digital touchpoints through 2025.\u003c\/p\u003e\n\u003cp\u003eReal-time analytics from Mario enable personalized care interventions tied to a 6-point improvement in HEDIS-like preventive metric performance in 2025 versus 2023.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarket Leadership in the Affordable Care Act (ACA) Space\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOscar Health has become a leading ACA individual-exchange player, holding top-three market share in key states like New York and California and enrolling about 1.2 million members nationwide by year-end 2025; its mobile-first brand appeals to digital-native consumers and lets Oscar profitably serve the individual market where legacy carriers often lose money, creating high retention and a loyal member base that values a simpler user experience.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Member Engagement and Digital Adoption\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOscar Health reports a 65% monthly active rate on its mobile app and 78% of members used digital care tools in 2025; its Virtual Urgent Care plus primary care integrations cut avoidable ER visits by 22% year-over-year through Q4 2025, lowering total cost of care by an estimated $210 per member annually, and the resulting claims and engagement data feed models that refine outreach and clinical interventions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Pivot to Sustained Profitability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cposcar health posted positive adjusted ebitda of million and gaap net income in entered with continued profitability a strengthened cash balance million.\u003e\n\u003cpmanagement shifted from growth-at-all-costs to disciplined underwriting holding medical loss ratio near while growing membership million lives investor confidence and reducing capital strain.\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003e2024 adj. EBITDA $120M; 2024 net income $45M\u003c\/li\u003e\u003cli\u003eCash reserves ~$850M entering 2026\u003c\/li\u003e\u003cli\u003eMembership ~1.2M lives\u003c\/li\u003e\u003cli\u003eMLR ~85%\u003c\/li\u003e\n\u003c\/pmanagement\u003e\u003c\/poscar\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpansion of the +Oscar Platform-as-a-Service\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp platform-as-a-service commercializes oscar tech creating a software revenue stream that reduces reliance on insurance risk and lifts margins in contributed about of total per health form\u003e\u003c\/p\u003e\n\u003cp selling engagement tools and an administrative stack to health systems payers oscar builds a high-margin b2b business margins for platform services exceed in reported quarters scalable unit economics.\u003e\u003c\/p\u003e\n\u003cp b2b expansion enhances company valuation by highlighting recurring scalable software income that complements insurance underwriting investors value such mixes at higher revenue multiples.\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e+Oscar revenue ~ $120M (2024)\u003c\/li\u003e\n\u003cli\u003eB2B gross margins \u0026gt;60%\u003c\/li\u003e\n\u003cli\u003ePlatform = recurring, scalable revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOscar: Digital-first growth—1.2M members, improved metrics, stabilized profitability\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOscar’s Mario platform drives lower admin costs (8–10% below peers), faster feature cadence (weeks), and improved preventive metrics (+6 points vs 2023); digital-first individual-exchange strength reached ~1.2M members with 65% app MAU and ER visits down 22% (2025). Profitability stabilized: 2024 adj. EBITDA $120M, GAAP net income $45M, cash ~$850M entering 2026; +Oscar SaaS revenue ~$120M (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMembers\u003c\/td\u003e\n\u003ctd\u003e~1.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eApp MAU\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdj. EBITDA (2024)\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGAAP Net Income (2024)\u003c\/td\u003e\n\u003ctd\u003e$45M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash (entering 2026)\u003c\/td\u003e\n\u003ctd\u003e$850M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e+Oscar Revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMLR\u003c\/td\u003e\n\u003ctd\u003e~85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT overview of Oscar Health, highlighting internal strengths and weaknesses alongside external opportunities and threats to evaluate its competitive position and strategic prospects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise Oscar Health SWOT snapshot for quick strategic alignment and stakeholder-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeographic Concentration and Market Sensitivity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOscar Health remains heavily weighted in Florida, Texas, and Georgia; as of YE 2024 about 58% of individual and ACA enrollment came from those states, so local regulatory or competitive shifts could hit membership hard.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLimited Product Diversification Outside the ACA\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOscar Health generates roughly 60–70% of revenue from the individual ACA exchange (2024 filings), despite testing Medicare Advantage and small-group offerings.\u003c\/p\u003e\n\u003cp\u003eThis concentration exposes Oscar to changes in federal ACA subsidy policy; a rollback could cut premiums and enrollment sharply.\u003c\/p\u003e\n\u003cp\u003eOscar’s 2024 commercial and Medicaid revenues remain under 30% combined, so they lack scale to offset major exchange losses.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHistorically High Medical Loss Ratios\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOscar Health has historically reported higher medical loss ratios (MLRs) than large peers—around 86–92% in 2019–2021 versus industry averages near 82%—driven by a younger, volatile member mix.\u003c\/p\u003e\n\u003cp\u003eAttracting members who deferred care raises acuity spikes; Oscar noted elevated utilization after open enrollment periods in 2022–2024, stressing margins.\u003c\/p\u003e\n\u003cp\u003eConsistent underwriting accuracy is essential: if medical costs rise 5–10% faster than premiums in competitive markets, loss ratios can exceed break-even thresholds and erode operating income.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDependence on Government Subsidies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eA large share of Oscar Health members depend on Advanced Premium Tax Credits (APTCs); in 2024 about 62% of Oscar’s ACA exchange enrollment received APTCs, per company filings. If Congress ends enhanced subsidies or funding drops, Oscar could face a rapid enrollment decline and revenue loss—APTC-driven premiums made up an estimated 55% of Oscar's 2024 exchange premium revenue. This creates systemic, politically driven risk beyond company control.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~62% of exchange members received APTCs (2024)\u003c\/li\u003e\n\u003cli\u003eAPTCs ≈55% of 2024 exchange premium revenue\u003c\/li\u003e\n\u003cli\u003eEnrollment and revenue exposed to federal subsidy changes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand Perception vs. Traditional Provider Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOscar’s narrow-network model—used in markets like New York and California—can be seen as restrictive by consumers wanting broad specialist or hospital access; 2024 enrollment surveys showed 22% cited provider choice as a top concern.\u003c\/p\u003e\n\u003cp\u003eWhile tighter networks trimmed medical cost trend by ~3–4% in 2023, departures of key providers have driven localized retention drops up to 8% in some counties.\u003c\/p\u003e\n\u003cp\u003eBalancing cost control with network adequacy is operationally sensitive: losing a major hospital system can spike out-of-network claims and member complaints quickly.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNarrow networks reduce costs (~3–4% medical trend)\u003c\/li\u003e\n\u003cli\u003e22% of enrollees (2024) cite limited providers as a concern\u003c\/li\u003e\n\u003cli\u003eProvider exits have caused up to 8% retention declines locally\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOscar: High ACA, state concentration and subsidy dependence threaten margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOscar’s revenue and enrollment are highly concentrated in FL, TX, GA (≈58% of ACA members YE2024) and on ACA individual plans (60–70% of revenue in 2024), exposing it to subsidy or state-policy shocks; APTC reliance was ~62% of members and ≈55% of 2024 exchange premium revenue. High MLRs (86–92% 2019–2021) and narrow networks (22% cite limited providers 2024) pressure margins and retention.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eConcentration (FL,TX,GA)\u003c\/td\u003e\n\u003ctd\u003e≈58% ACA enrollment YE2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eACA revenue share\u003c\/td\u003e\n\u003ctd\u003e60–70% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAPTC recipients\u003c\/td\u003e\n\u003ctd\u003e≈62% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAPTC of exchange revenue\u003c\/td\u003e\n\u003ctd\u003e≈55% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHistoric MLR\u003c\/td\u003e\n\u003ctd\u003e86–92% (2019–2021)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProvider choice concern\u003c\/td\u003e\n\u003ctd\u003e22% cite (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eOscar Health SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full SWOT report you'll get, and the content shown is the real, editable file included in your download. You’re viewing a live preview of the complete analysis; buy now to unlock the full, detailed report immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752352788857,"sku":"hioscar-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/hioscar-swot-analysis.png?v=1772239924","url":"https:\/\/matrixbcg.com\/products\/hioscar-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}